FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Jun 15, 2012
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on June 15, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- June 15, 2012
- Product Type
- Biologics
View Company Profile
ID · a4434d93-9fcc-49da-b3aa-ed7b2e01cf3d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 786511
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 27, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 14, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1069022 - 2018-09-21
- FDA Inspection 959868 - 2016-01-27
- FDA Inspection 878532 - 2014-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.